Education
About Us
Working with TipRanks
Follow Us
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
YMAB Analyst Ratings
Moderate Buy
8 Buy
1 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
YMAB Stock 12 Month Forecast
Average Price Target
$16.70
▲(245.04% Upside)
| Highest Price Target$26.00 | Average Price Target$16.70 | Lowest Price Target$7.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
03/21/25
Truist Financial
Reiterated
03/05/25
JonesTrading
Reiterated
03/05/25
Oppenheimer
Reiterated
03/05/25
Clear Street
Reiterated
03/04/25
Brookline Capital Markets
Reiterated
03/04/25
Morgan Stanley
Reiterated
03/04/25
Canaccord Genuity
Reiterated
03/04/25
Bank of America Securities
Reiterated
03/04/25
Cantor Fitzgerald
Reiterated
03/04/25
Unknown Analyst
Not Ranked
Wedbush
$23
Buy
375.21%
Upside
Reiterated
09/10/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
03/21/25
Truist Financial
Reiterated
03/05/25
JonesTrading
Reiterated
03/05/25
Oppenheimer
Reiterated
03/05/25
Clear Street
Reiterated
03/04/25
Brookline Capital Markets
Reiterated
03/04/25
Morgan Stanley
Reiterated
03/04/25
Canaccord Genuity
Reiterated
03/04/25
Bank of America Securities
Reiterated
03/04/25
Cantor Fitzgerald
Reiterated
03/04/25
Unknown Analyst
Not Ranked
Wedbush
$23
Buy
375.21%
Upside
Reiterated
09/10/24
YMAB Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
6
8
10
6
11
Buy
3
3
3
2
2
Hold
1
1
2
3
5
Sell
2
2
2
1
2
Strong Sell
0
0
0
0
0
total
12
14
17
12
20
Each month's total comprises the sum of three months' worth of ratings.
YMAB Financial Forecast
YMAB Stock Forecast FAQ
What is YMAB’s average 12-month price target, according to analysts?
Based on analyst ratings, Y-Mabs Therapeutics’s 12-month average price target is $16.70.
What is YMAB’s upside potential, based on the analysts’ average price target?
Y-Mabs Therapeutics has 245.04% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is YMAB a Buy, Sell or Hold?
Y-Mabs Therapeutics has a consensus rating of Moderate Buy which is based on 8 buy ratings, 1 hold ratings and 1 sell ratings.
What is Y-Mabs Therapeutics’s price target?
The average price target for Y-Mabs Therapeutics is $16.70. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $26.00 ,the lowest forecast is $7.00. The average price target represents 245.04% Increase from the current price of $4.84.
The highest analyst price target is $26.00 ,the lowest forecast is $7.00. The average price target represents 245.04% Increase from the current price of $4.84.
What do analysts say about Y-Mabs Therapeutics?
Y-Mabs Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of YMAB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.